Eli Lilly Reaches Historic Trillion-Dollar Valuation
Published on 11/22/2025 at 11:53 | Redaktion boerse-global.de
Eli Lilly has achieved a monumental financial milestone, becoming the first pharmaceutical company ever to surpass a $1 trillion market capitalization. This elevates the Indianapolis-based firm into an elite category previously dominated solely by technology behemoths such as Apple, Microsoft, and Alphabet. With its share price reaching approximately $1,048, the company’s ascent underscores that the weight-loss drug revolution represents a fundamental market shift, not a temporary trend.
The company’s financial performance for the third quarter of 2025 was nothing short of explosive. Revenue hit $17.6 billion, marking a staggering 54 percent increase compared to the same period last year. This result substantially exceeded market expert projections, which had anticipated revenue of around $16 billion.
This Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
